Ultralife Corporation
ULBI
$5.68
-$0.09-1.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 186.53M | 178.85M | 173.28M | 164.46M | 165.15M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 186.53M | 178.85M | 173.28M | 164.46M | 165.15M |
| Cost of Revenue | 141.89M | 135.15M | 129.63M | 122.14M | 122.04M |
| Gross Profit | 44.64M | 43.71M | 43.65M | 42.31M | 43.12M |
| SG&A Expenses | 27.79M | 26.49M | 25.25M | 24.08M | 23.02M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 179.67M | 170.87M | 163.79M | 154.49M | 152.76M |
| Operating Income | 6.86M | 7.98M | 9.49M | 9.97M | 12.39M |
| Income Before Tax | 2.30M | 4.41M | 7.14M | 8.30M | 10.92M |
| Income Tax Expenses | 568.00K | 1.15M | 1.76M | 1.89M | 1.89M |
| Earnings from Continuing Operations | 1.74 | 3.26 | 5.38 | 6.41 | 9.03 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -17.00K | -65.00K | -98.00K | -97.00K | -35.00K |
| Net Income | 1.72M | 3.20M | 5.29M | 6.31M | 8.99M |
| EBIT | 6.86M | 7.98M | 9.49M | 9.97M | 12.39M |
| EBITDA | 12.24M | 12.93M | 14.03M | 14.12M | 16.33M |
| EPS Basic | 0.10 | 0.19 | 0.32 | 0.38 | 0.55 |
| Normalized Basic EPS | 0.11 | 0.17 | 0.27 | 0.31 | 0.36 |
| EPS Diluted | 0.10 | 0.19 | 0.32 | 0.38 | 0.54 |
| Normalized Diluted EPS | 0.11 | 0.17 | 0.27 | 0.31 | 0.36 |
| Average Basic Shares Outstanding | 66.54M | 66.52M | 66.46M | 66.22M | 65.93M |
| Average Diluted Shares Outstanding | 66.74M | 66.97M | 67.14M | 66.98M | 66.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |